After-Hours Stock Movers:
Spectrum Pharmaceuticals (Nasdaq: SPPI) 27.7% LOWER; The FDA's Oncologic Drugs Advisory Committee (ODAC) met to review poziotinib for the treatment of patients with previously treated locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring HER2 exon 20 insertion mutations. The committee voted 9-4 that the current benefits of poziotinib did not outweigh its risks.
Avenue Therapeutics, Inc. (Nasdaq: ATXI) 24.6% HIGHER; announced that it will effect a 1-for-15 reverse split of its common stock.
Cano Health, Inc. (NYSE: CANO) 7.6% HIGHER; adds to 32% intra-day gains on reports it is for sale with multiple bidders.
Calamp Corp. (NASDAQ: CAMP) 3.5% HIGHER; reported Q2 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $72.8 million versus the consensus estimate of $69.27 million.
Costco (NASDAQ: COST) 2.4% LOWER; reported Q4 EPS of $4.20, $0.05 better than the analyst estimate of $4.15. Revenue for the quarter came in at $72.09 billion versus the consensus estimate of $71.64 billion.
Guidewire (NYSE: GWRE) 2.5% HIGHER; announced that its board of directors approved a share repurchase program with authorization to purchase up to $400.0 million of its outstanding shares of Common Stock, effective immediately.
Trevi Therapeutics, Inc. (Nasdaq: TRVI) 3.9% LOWER; commenced an underwritten public offering of shares of its common stock.
